Mohammed Mawla, DO
Physical Medicine & Rehabilitation · Springfield, MANPI 1689836702
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $409 and has fallen 73.1% since, to $110 in 2025.
Across 112 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$396
- Pfizer$352
- Biohaven Pharmaceutical Holding Company Ltd.$315
- Biohaven Pharmaceuticals, Inc.$259
- Lilly USA, LLC$186
- Bioventus LLC$86
- plus $257 from 5 others
What the payments were for
- Food & beverage$1,850100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 45 | $396 |
| Pfizer | 17 | $352 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $315 |
| Biohaven Pharmaceuticals, Inc. | 10 | $259 |
| Lilly USA, LLC | 9 | $186 |
| Bioventus LLC | 3 | $86 |
| Johnson & Johnson | 4 | $84 |
| Vertex | 3 | $67 |
| Assertio Therapeutics, Inc. | 2 | $45 |
| AbbVie(2 entities) | 2 | $38 |
| Redhill Biopharma Inc. | 1 | $23 |
How this compares
$1,850 in reported general payments places this provider in the 85th percentile of 244 physical medicine & rehabilitation providers in Massachusetts.
See all physical medicine & rehabilitation providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $638 |
| Diclofenac Sodium | 28 | $538 |
| Gabapentin | 42 | $410 |
| Baclofen | 35 | $364 |
| Topiramate | 27 | $281 |
| Oxycodone Hcl | 12 | $175 |
| Tramadol Hcl | 33 | $162 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Springfield
- Robert KaplanSpringfield$2K
- Deepthi GantaSpringfield$2K
- Howard LedermanSpringfield$2K
- Paul AzimovSpringfield$491
- Zachary BohartBurlington$633K
- Sabrina PaganoniCharlestown$80K
- Walter SussmanWellesley$50K
- Stephen KoelbelWeymouth$24K
- Moorice CaparoCharlestown$18K
- Didem InanogluBoston$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.